Last updated on May 2017

Safety Tolerability Pharmacokinetics and Pharmacodynamics of IONIS ANGPTL3-LRx in Healthy Volunteers With Elevated Triglycerides and Subjects With Familial Hypercholesterolemia


Brief description of study

The purpose is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of IONIS ANGPTL3-LRx (ISIS 703802) given to healthy volunteer subjects with elevated triglycerides and subjects with familial hypercholesterolemia.

Clinical Study Identifier: NCT02709850

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Ionis Pharmaceuticals

Clinical Site
Toronto, ON Canada
  Connect »